Kuros Biosciences AG CSBTF:OTCPK

*Data is delayed | Exchange | USD
Last | 04/22/24 EDT
9.05UNCH (UNCH)
52 week range
2.13 - 9.05
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close9.05
  • 52 Week High9.05
  • 52 Week High Date04/22/24
  • 52 Week Low2.13
  • 52 Week Low Date09/07/23

Key Stats

  • Market Cap302.36M
  • Shares Out36.77M
  • 10 Day Average Volume1,433.33
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change135.03

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close9.05
  • 52 Week High9.05
  • 52 Week High Date04/22/24
  • 52 Week Low2.13
  • 52 Week Low Date09/07/23
  • Market Cap302.36M
  • Shares Out36.77M
  • 10 Day Average Volume1,433.33
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change135.03

RATIOS/PROFITABILITY

  • EPS (TTM)-0.44
  • P/E (TTM)-20.60
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kuros Biosciences AG

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Kuros Biosciences AG is a Switzerland-based biotechnology company engaged in the discovery, development and commercialization of biopharmaceutical products known as Immunodrugs. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic diseases, asthma, malignant melanoma and Alzheimer's disease. They are designed to instruct the patient's immune system to produce desired therapeutic...
Clemens Van Blitterswijk Ph.D.
Non-Executive Chairman of the Board of Directors
Chris Fair
Chief Executive Officer, Member of the Executive Board
Sjoerd Musters
Chief Operating Officer, Member of the Executive Board
Daniel Geiger
Chief Financial Officer, Member of the Executive Board
Address
Wagistrasse 25
Schlieren
8952
Switzerland